Stock NN6 NANOREPRO AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials NanoRepro AG

Equities

NN6

DE0006577109

Medical Equipment, Supplies & Distribution

Market Closed - Xetra
Other stock markets
 16:36:16 26/06/2024 BST 		5-day change 1st Jan Change
1.695 EUR +0.30% Intraday chart for NanoRepro AG -1.45% -15.04%
06-06 NanoRepro AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 8.395 5.98 35.08 96.65 28.45 25.69
Enterprise Value (EV) 1 6.626 5.441 35.27 68.78 -2.807 5.07
P/E ratio -29 x -5.03 x 20.7 x 3.26 x -7.64 x -5.41 x
Yield - - - 6.68% 6.8% -
Capitalization / Revenue 3.05 x 3.31 x 2.07 x 0.59 x 0.73 x 8.07 x
EV / Revenue 2.41 x 3.01 x 2.08 x 0.42 x -0.07 x 1.59 x
EV / EBITDA 426 x -6.26 x 7.56 x 1.77 x 0.62 x -0.95 x
EV / FCF -12.8 x -7.65 x -6.54 x -9.85 x -0.14 x -1.41 x
FCF Yield -7.82% -13.1% -15.3% -10.2% -724% -71.1%
Price to Book 1.49 x 1.35 x 4.39 x 1.68 x 0.6 x 0.63 x
Nbr of stocks (in thousands) 8,480 8,482 9,331 12,904 12,904 12,878
Reference price 2 0.9900 0.7050 3.760 7.490 2.205 1.995
Announcement Date 28/03/19 25/05/20 21/05/21 13/06/22 04/05/23 06/06/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2.749 1.806 16.93 162.7 38.79 3.184
EBITDA 1 0.0156 -0.8692 4.665 38.82 -4.525 -5.321
EBIT 1 -0.3234 -1.181 4.653 38.81 -4.534 -5.342
Operating Margin -11.77% -65.43% 27.49% 23.85% -11.69% -167.78%
Earnings before Tax (EBT) 1 -0.3306 -1.188 2.78 38.76 -4.364 -4.685
Net income 1 -0.2896 -1.189 1.695 29.72 -3.724 -4.685
Net margin -10.54% -65.83% 10.01% 18.27% -9.6% -147.17%
EPS 2 -0.0341 -0.1401 0.1817 2.300 -0.2886 -0.3685
Free Cash Flow 1 -0.5184 -0.7108 -5.39 -6.983 20.32 -3.603
FCF margin -18.86% -39.37% -31.84% -4.29% 52.38% -113.18%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - 0.5000 0.1500 -
Announcement Date 28/03/19 25/05/20 21/05/21 13/06/22 04/05/23 06/06/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 0.19 - - -
Net Cash position 1 1.77 0.54 - 27.9 31.3 20.6
Leverage (Debt/EBITDA) - - 0.0403 x - - -
Free Cash Flow 1 -0.52 -0.71 -5.39 -6.98 20.3 -3.6
ROE (net income / shareholders' equity) -6.13% -23.7% 27.3% 90.6% -7.09% -10.7%
ROA (Net income/ Total Assets) -4.04% -13.9% 36.4% 53.7% -4.41% -7.34%
Assets 1 7.166 8.539 4.655 55.34 84.53 63.81
Book Value Per Share 2 0.6600 0.5200 0.8600 4.460 3.680 3.180
Cash Flow per Share 2 0.2100 0.0900 0.1200 2.170 2.420 1.310
Capex - - 0 0 0 -
Capex / Sales - - 0% 0% 0% -
Announcement Date 28/03/19 25/05/20 21/05/21 13/06/22 04/05/23 06/06/24
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
NANOREPRO AG Stock NanoRepro AG
-15.04% 23M
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.38% 184B
MEDTRONIC PLC Stock Medtronic plc
-3.02% 103B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.80% 67.59B
CENCORA, INC. Stock Cencora, Inc.
+15.74% 46.93B
DEXCOM, INC. Stock DexCom, Inc.
-8.79% 43.87B
HOYA CORPORATION Stock Hoya Corporation
+8.28% 41.2B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+17.38% 30.47B
TERUMO CORPORATION Stock Terumo Corporation
+13.59% 24.16B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-7.40% 23.57B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NN6 Stock
  4. Financials NanoRepro AG